Literature DB >> 14978756

Lentiviral vectors: optimization of packaging, transduction and gene expression.

Christophe Delenda1.   

Abstract

Gene transfer vectors based on retroviruses including oncogenic retroviruses and lentiviruses provide effective means for the delivery, integration and expression of exogenous genes in mammalian cells. Lentiviral (LV) vectors provide attractive gene delivery vehicles in the context of non-dividing cells. This review summarizes the different optimized LV genetic systems that have been developed to date. In all cases, the production of LV-derived vectors consists of a genetically split gene expression design. The viral elements that are specifically required are (i). the LV packaging helper proteins consisting of at least the gag-pol genes, (ii). the LV transfer vector RNA containing the transgene expression cassette, and (iii). an heterologous glycoprotein. While the genetic requirements and performances of the two former viral elements will be treated herein, the latter element relative to the envelope pseudotyping of LV vectors will not be further described (cf. review by Cosset in this issue). Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978756     DOI: 10.1002/jgm.501

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  28 in total

Review 1.  Viral vectors: from virology to transgene expression.

Authors:  D Bouard; D Alazard-Dany; F-L Cosset
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

2.  The beta-catenin binding protein ICAT modulates androgen receptor activity.

Authors:  Ming Zhuo; Chunfang Zhu; JingLucy Sun; William I Weis; Zijie Sun
Journal:  Mol Endocrinol       Date:  2011-09-01

3.  Transfection of nerve cells.

Authors:  S V Salozhin; A P Bol'shakov
Journal:  Neurosci Behav Physiol       Date:  2010-02-10

Review 4.  Engineering T Cells to Functionally Cure HIV-1 Infection.

Authors:  Rachel S Leibman; James L Riley
Journal:  Mol Ther       Date:  2015-04-21       Impact factor: 11.454

5.  A novel role for protein inhibitor of activated STAT (PIAS) proteins in modulating the activity of Zimp7, a novel PIAS-like protein, in androgen receptor-mediated transcription.

Authors:  Yue Peng; Jane Lee; Chunfang Zhu; Zijie Sun
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

Review 6.  Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy.

Authors:  Ziying Yan; Zoe A Stewart; Patrick L Sinn; John C Olsen; Jim Hu; Paul B McCray; John F Engelhardt
Journal:  Hum Gene Ther Clin Dev       Date:  2015-02-12       Impact factor: 5.032

Review 7.  Gene targeting in primary human trophoblasts.

Authors:  F J Rosario; Y Sadovsky; T Jansson
Journal:  Placenta       Date:  2012-07-23       Impact factor: 3.481

8.  Method for Efficient Transduction of Cancer Stem Cells.

Authors:  Kiera Walker; Anita Hjelmeland
Journal:  J Cancer Stem Cell Res       Date:  2014-12-01

9.  Lentiviral-mediated phenotypic correction of cystic fibrosis pigs.

Authors:  Ashley L Cooney; Mahmoud H Abou Alaiwa; Viral S Shah; Drake C Bouzek; Mallory R Stroik; Linda S Powers; Nick D Gansemer; David K Meyerholz; Michael J Welsh; David A Stoltz; Patrick L Sinn; Paul B McCray
Journal:  JCI Insight       Date:  2016-09-08

10.  Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).

Authors:  Joanna L Howarth; Youn Bok Lee; James B Uney
Journal:  Cell Biol Toxicol       Date:  2009-10-15       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.